Elekta AB/Skr EKTA B
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About Elekta AB
Elekta AB is a Swedish company specializing in the development and production of medical technologies used in radiotherapy and radiosurgery for treating cancer and brain disorders. Founded in 1972 and headquartered in Stockholm, Sweden, Elekta offers a range of products including linear accelerators, brachytherapy solutions, and software for treatment planning and digital health records management. The company is recognized for its emphasis on precision and efficiency in treatment delivery. Elekta operates globally, serving hospitals and cancer care centers across multiple continents, leveraging technological innovations to improve patient outcomes and workflow efficiency in healthcare facilities. Its strategic focus includes the continuous advancement of image-guided radiation therapy technologies.
Ticker
Skr EKTA B
Sector
Primary listing
XSTO
Employees
3,704
Headquarters
Stockholm, Sweden
Website
Elekta AB Metrics
BasicAdvanced
kr 19bn
-
-kr 1.36
0.96
kr 2.40
4.91%
Price and volume
Market cap
kr 19bn
Beta
0.96
52-week high
kr 66.70
52-week low
kr 41.86
Average daily volume
1.1m
Dividend rate
kr 2.40
Financial strength
Current ratio
0.87
Quick ratio
0.624
Long term debt to equity
57.89
Total debt to equity
102.56
Interest coverage (TTM)
4.79%
Profitability
EBITDA (TTM)
1,433
Gross margin (TTM)
38.38%
Net profit margin (TTM)
-3.10%
Operating margin (TTM)
8.17%
Effective tax rate (TTM)
-279.41%
Revenue per employee (TTM)
kr 4,510,000
Management effectiveness
Return on assets (TTM)
3.05%
Return on equity (TTM)
-6.45%
Valuation
Price to revenue (TTM)
1.116
Price to book
2.62
Price to tangible book (TTM)
-5.13
Price to free cash flow (TTM)
13.406
Free cash flow yield (TTM)
7.46%
Free cash flow per share (TTM)
3.643
Dividend yield (TTM)
4.91%
Growth
Revenue change (TTM)
-7.20%
Earnings per share change (TTM)
-319.35%
3-year revenue growth (CAGR)
-0.30%
10-year revenue growth (CAGR)
4.07%
3-year earnings per share growth (CAGR)
-18.02%
10-year earnings per share growth (CAGR)
14.24%
10-year dividend per share growth (CAGR)
16.98%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.